Emergency Medicine Doctors in Ohio Medicare Details, Address, Contact

2582 Emergency Medicine doctors found. Showing 21 - 40

Scott Winot, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 300-344-6000

Dr. Patricia Khatib, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Department Of Emergency Medicine, Akron, OH 44307 Phone: 330-344-6000

Carole Parsons, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6000

Lauren R Weber, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 525 E Market St, Summa Health System/ Emergency Medicine Department, Akron, OH 44304 Phone: 330-375-9634

Kassidy Wilson, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 141 N Forge St, Akron, OH 44304 Phone: 734-788-9747

Dr. Allison M Finley, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 41 Arch St, Suite 513, Akron, OH 44304 Phone: 330-375-4021

Jonathan Jacob Oskvarek, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 141 N Forge St, Akron, OH 44304 Phone: 630-222-2132

Sarah Michelle Gleason, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-3000

George Goldman, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-3369    Fax: 330-375-3769

David Custodio, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-3369    Fax: 330-375-6769

Marcel Nwizu, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6000

Nathaniel Pavkov, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4040 Embassy Pkwy Ste 370, Akron, OH 44333 Phone: 234-466-8633    Fax: 234-466-8502

Matthew Voll, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1077 Gorge Blvd, Akron, OH 44310 Phone: 330-375-4045

Ozlem Bilgen, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-3107

Brian Keaton, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-3369    Fax: 330-375-3769

Dr. Chioma Enweani Ojiaku, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6000

Christopher K Corbit, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 400 Wabash Ave, Akron, OH 44307 Phone: 330-344-1799    Fax: 330-253-8293

Michael John Glueckert, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-3361

Colleen Marie Mcquown, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-9634    Fax: 330-375-3769

Dr. Nicholas Philip Shundry, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-3000

News Archive

Salicylates drugs reduce proliferation, viability of cultured vestibular schwannoma cells

Researchers from Massachusetts Eye and Ear and the Harvard Medical School/ Massachusetts Institute of Technology's Program in Speech and Hearing Bioscience and Technology have demonstrated that salicylates, a class of non-steroidal inflammatory drugs (NSAIDs), reduced the proliferation and viability of cultured vestibular schwannoma cells that cause a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus.

New project aims to develop a digital health solution for promoting COVID-19 vaccination

Patients with compromised health conditions, such as multiple sclerosis, are at enhanced risk of contracting COVID-19.

ODAC calls for randomized study of Vion's Onrigin injection for treatment of the elderly AML patients

VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) today announced the results of the Oncologic Drugs Advisory Committee (ODAC) Meeting at which data for its lead oncology therapeutic Onrigin(TM)(laromustine) Injection were presented for the indication of remission induction treatment for patients sixty years of age or older with de novo poor-risk acute myeloid leukemia (AML).

Tuberculosis on the rise in the UK

Provisional figures released by the Health Protection Agency for 2006 show that cases of tuberculosis (TB) in England , Wales and Northern Ireland have increased 2% from 8,008 cases reported in 2005 to 8,171 in 2006.

Read more Medical News

› Verified 5 days ago

• 1
• 2(current)
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• »